Published in

Nature Research, Nature Immunology, 7(14), p. 696-697, 2013

DOI: 10.1038/ni.2646

Links

Tools

Export citation

Search in Google Scholar

Regulation unmasked by activation

Journal article published in 2013 by Mike Clark ORCID, Anne Cooke
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

The glycoprotein CD52 is an important target for clinical antibodies, but its receptor and function have remained a mystery. However, it now seems that CD52 may be released in soluble form by a subpopulation of human T cells and may thereby exert an as-yet-unrecognized regulatory function via the inhibitory molecule Siglec-10.